Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation
Eiko N. Minakawa(National Center of Neurology and Psychiatry), Yoshitaka Nagai(Meiji University)
Cited by 38
Related Papers
Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
|Human Molecular Genetics|2006|207
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
|Frontiers in Neuroscience|2021|52
Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1
|Scientific Reports|2015|20